Oxytocin antagonists: The next frontier in PE treatment
Yükleniyor...
Tarih
2019
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Nature Publishing Group
Erişim Hakkı
info:eu-repo/semantics/embargoedAccess
Özet
Oxytocin antagonists seem to have potential as a treatment option for premature ejaculation (PE), but the parameters of their use are vague. Two recently published studies highlight the need for large-scale trials to elucidate the value of these drugs in the treatment of PE.
Açıklama
Anahtar Kelimeler
Intravaginal Ejaculatory Latency, Premature Ejaculation, Double-Blind, Receptor Antagonist, Men, Cligosiban, Efficacy, Safety
Kaynak
Nature Reviews Urology
WoS Q Değeri
Q1
Scopus Q Değeri
Q1
Cilt
16
Sayı
12
Künye
Gül, M. ve Şerefoğlu, E. C. (2019). Oxytocin antagonists: The next frontier in PE treatment. Nature Reviews Urology, 16(12), 696-697. https://doi.org/10.1038/s41585-019-0238-7
